Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

317.50p
   
  • Change Today:
      2.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 291,193
  • Market Cap: £317.50m
  • RiskGrade: 125

Cash Flow

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Cash Flow Statement 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-10 31-Dec-09
           
Net Cash Flow From Operating Activities 3.12 (3.51) 12.87 (12.83) 2.31
ROI, Servicing of Finance          
Assocs/JV Dividends Received bn/a bn/a bn/a bn/a bn/a
Interests & Other Dividends Received n/a n/a n/a n/a n/a
Interest Paid bn/a bn/a bn/a bn/a bn/a
Minorities & Non-Equity Divs Paid bn/a bn/a bn/a bn/a bn/a
  n/a n/a n/a n/a n/a
           
Taxation Paid bn/a bn/a bn/a bn/a bn/a
           
Gross Cash Flow bn/a bn/a bn/a bn/a bn/a
           
Capital Expd & Financial Inv          
Interests & Other Dividends Received 0.03 0.10 0.05 n/a n/a
Disposal of Property, Plant & Equipment n/a n/a n/a n/a n/a
Disposal of Investments 2.52 6.27 n/a 12.93 n/a
Purchase of Property, Plant & Equipment (13.36) (25.77) (10.10) (0.29) (0.25)
Purchase of Investments n/a n/a n/a n/a (4.75)
Net Purchase of Intangible Assets n/a n/a (0.04) (0.27) (0.04)
Other Investing Cash Flow n/a n/a n/a n/a n/a
  (10.80) (19.40) (10.10) 12.38 (5.04)
Financing Activities          
Dividends Paid n/a n/a n/a n/a n/a
Repayments of Borrowings (1.15) (44.42) n/a n/a n/a
Borrowings n/a n/a n/a n/a n/a
Other Financing Cash Flow 39.34 51.33 15.14 0.30 1.39
  38.18 6.90 15.14 0.30 1.39
Net Increase/Decrease In Cash 30.50 (16.00) 17.91 (0.15) (1.33)


Key Financials 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-10 31-Dec-09
           
Shares in Issue - Year End 83.32 n/a 66.10 544.88 541.19
           
Financial Data          
Cash Incr/Decr per Share 38.15p (22.01p) 3.43p (0.027p) (0.25p)
Operating Cash Flow per Share 3.90p (4.83p) 19.74p (2.36p) 0.43p
Gross Cash Flow per Share bn/a bn/a bn/a bn/a bn/a
           
Market Data          
Price/Operating Cash Flow 264.3 (133.7) 35.8 (117.2) 1,244.2

Key

* GAAP

a. Operating activities before tax

b. Not disclosed under IFRS

c. Not previously included in financing activities

d. Based on operating cash flow before tax

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page